Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Tianjin Bolang Science-Technology Development Co., Ltd.
WARNING LETTER
•Tianjin Bolang Science-Technology Development Co., Ltd.•March 30, 2021

Tianjin Bolang Science-Technology Development Co., Ltd. – FDA Warning Letter, Mar 30, 2021

Record Details

On June 17, 2021, the FDA issued a Warning Letter to Hi-Tech Green Industrial Base in Tianjin, China, following an inspection from March 22-30, 2021. The inspection revealed that the firm's manufactured devices, including Otoscopes, Rigid Laryngoscopes, and Rigid Nasopharyngoscopes, are adulterated under 21 U.S.C. § 351(h) due to non-conformity with the Quality System (QS) regulation (21 CFR Part 820). Additionally, the Class II Rigid Nasopharyngoscope devices are misbranded under 21 U.S.C. § 352(t)(2) for failing to provide information required by Medical Device Reporting (MDR) regulations (21 CFR Part 803).

Significant violations include the failure to establish and maintain procedures for design control (21 CFR 820.30(a)), corrective and preventive actions (21 CFR 820.100(a)), complaint handling (21 CFR 820.198(a)), and control and distribution of finished devices (21 CFR 820.160). The firm also failed to maintain Device Master Records (21 CFR 820.181), Device History Records (21 CFR 820.184), and a Quality System Record (21 CFR 820.186). Furthermore, the firm lacked sufficient personnel with adequate training and experience (21 CFR 820.25(a)) and failed to develop written MDR procedures (21 CFR 803.17).

The firm's April 19, 2021, response to the FDA 483 observations was largely deemed inadequate due to a lack of detail, missing procedures, or insufficient evidence of implementation. Consequently, the firm's devices are subject to refusal of admission into the U.S. under section 801(a) of the Act. Hi-Tech Green Industrial Base must provide a written response within fifteen business days detailing specific corrective actions, prevention plans, and implementation timetables, including documentation, to address these systemic quality system and compliance issues.

Company
Tianjin Bolang Science-Technology Development Co., Ltd.
Inspection date
March 30, 2021
Product type
Devices
Office
Center for Devices and Radiological Health
Person
  • Malvina B. Eydelman (Office Director)
View Company Profile

ID · 156ae6e0-3c80-4e98-b039-e88df1f54c80

Violation Codes10
21 U.S.C. 321(h)21 U.S.C. 351(h)21 CFR 82021 CFR 820.30(a)21 CFR 820.100(a)21 CFR 820.198(a)21 CFR 820.16021 CFR 820.18121 CFR 820.18421 CFR 820.186

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Tianjin Bolang Science-Technology Development Co., Ltd.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.